Imaging Biometrics, creating the standard

When our clients come to us in search of help with difficult problems, they know that they can count on us to provide new insights and meaningful improvements, always with patient care as our highest priority. Through our close collaborations with top research minds in the medical imaging field, we help translate proprietary and sophisticated advancements into easy-to-use, intuitive software solutions for clinicians and researchers. Our mission is to help you get the most meaning out of your medical imaging studies. Our commitment is to serve patients by bringing only proven solutions to market, giving you assurance that when you are relying on our solutions, your team is providing the best care possible.

In The News

IB Phase I Clinical Trial

(Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma)

is enrolling patients! The trial is currently for patients with recurring GBM or GBM refractory to primary treatment.

Contact the Medical College of Wisconsin Cancer Center Clinical Trials Office at
414-805-8900, 866-680-0505 or cccto@mcw.edu

MORE INFORMATION

John Karis, MD

“When new areas of enhancement are identified, our surgeons and neuro-oncologists want to see IB’s Delta T1 and rCBV on our glioma patients to guide therapeutic and surgical management. The additional information added by IB’s rCBV mapping to conventional imaging is instrumental in patient management.”

Neuroradiologist
Southwest Neuro-Imaging Ltd

Anja G Van Der Kolk, MD, PhD

“I really enjoyed working with IB Neuro and the other plugins; it is very user-friendly and just beautifully made! And thank you for all your help and advice. I really appreciated it and very much liked working with you!”

Visiting Scientist, Nuclear Medicine & Neuroradiology
Department of Radiology
University of Wisconsin Hospitals and Clinics

Jennifer Connelly, MD

“The T1 with contrast is hard to interpret, but I think the Delta T1 says it all.”

Associate Professor, Neurology and Neuro-Oncology
Medical College of Wisconsin &
Froedtert Memorial Lutheran Hospital

Scott Rand, MD, PhD

“We appreciate the speed of IB products and their compatibility with PACS. More recently, we have started to use IB products for image-guided surgical planning. We anticipate their use for radiation therapy planning in the near future. Our Neurosurgeons, Radiation Oncologists and Neuro-Oncologists find perfusion scans and delta T1 maps of the brain to be very useful, and now routinely write orders to obtain this information.”

Professor of Radiology Medical College of Wisconsin & Froedtert Memorial Lutheran Hospital

Jerrold Boxerman, MD, PhD

“I have found the IB Neuro plugin to be a robust, accurate implementation of CBV algorithms cited in the literature. It is easy to use, and meshes nicely with our platform. We have found normalized CBV maps overlayed on contrast enhanced or FLAIR images to be very useful for brain tumor analysis and follow-up.”

Associate Professor of Radiology
Department of Diagnostic Imaging
Rhode Island Hospital

Cathy Marszalkowski

“IB plug-ins are a lifesaver. They have cut down my analysis time from hours to minutes.”

Clinical Research Coordinator
Froedtert Memorial Lutheran Hospital

Advanced Imaging in Neuro-Oncology

Magnetic Resonance Imaging (MRI) is the gold standard imaging technique used for diagnosing and grading brain tumors, as well as for imaging the brain to evaluate whether a selected therapy is working. While conventional MRI with contrast agent is able to show the location and extent of a brain tumor prior to surgery, it is less reliable for tumor grading and monitoring a tumor's response to therapy.

Advanced MRI techniques provide information about tumor physiology that is not available using conventional imaging. Perfusion MRI is able to depict areas of increased vascularity, which are often associated with more aggressive tumor growth. It can be used to identify areas in a tumor that are likely to be higher grade (i.e. more aggressive), for more effective biopsy targeting and treatment planning. In addition, perfusion MRI has proven useful during and after therapy for distinguishing between areas of tumor regrowth, and areas of normal tissue response to chemoradiation. Diffusion MRI provides valuable insights into how densely cells are packed together, which can also help distinguish invasive areas of tumor from other areas of concern on conventional MRI.

Imaging Biometrics solutions help care teams analyze advanced MR brain images with the most proven and reliable tools in the industry. At every point in the care pathway, our solutions are there with the insights you need to provide the best patient care possible.

Software & Services

IB CLINIC^® NEURO-ONCOLOGY APPLICATION SUITE

A complete suite of physiological imaging analysis tools for diagnosis, pre-surgical planning, treatment response monitoring and follow-up. Includes our flagship application, IB NEURO™ Perfusion MRI and CT analysis using dynamic susceptibility contrast images, and IB DELTA SUITE™ MR image registration and subtraction for improved comparison of post-contrast to pre-contrast images. IB DCE™ and IB DIFFUSION™ complete the analysis for advanced MRI.

IB CLINIC^® ONCOLOGY APPLICATIONS

IB DCE™ Perfusion MRI dynamic contrast enhancement analysis.

IB DIFFUSION™ Diffusion MRI analysis.

IB PARTNER SOLUTIONS

STONECHECKER™ Kidney stone CT image analysis.

CUSTOM SERVICES

Software application development and commercialization with academic and industry partners.

Research Study Using IB Software Wins Top Award from AJNR

The American Journal of Neuroradiology has announced that its annual Lucien Levy Best Research Article Award for 2019 is presented to: Performance of Standardized Relative CBV for Quantifying Regional Histologic Tumor Burden in Recurrent High-Grade Glioma: Comparison against Normalized Relative CBV Using Image-Localized Stereotactic Biopsies by J.M. Hoxworth et al.

The paper reports on a study led by Dr. Leland Hu, MD (The Mayo Clinic, AZ) using IB's Neuro-Oncology software. The study demonstrated the usefulness of IB’s vascular mapping analysis in the differentiation of recurrent high-grade brain tumor from treatment effect. In addition, the study showed that IB's Image Standardization method was able to reduce the number of time-consuming manual steps required without sacrificing reliability.